Requirements

All of it, in the shape the answers of 17/09/2026 gave it. The expert a pharma user meets is an anonymous card carrying profession, country and topic, and no name, no employer and no question text (OQ-05). A contact request is recorded, passed to the expert, and the identity is revealed only on acceptance, with the acceptance stored as a consent record naming the company and the wording shown (OQ-42). The link between a card and a person stays inside the signal layer, which no service outside it may read. 'Sustained and specific enquiry' is the topic score of OQ-06, built from the number, recency and specificity of questions, with the top 1.4 percent of a disease area flagged until the validation study replaces the cut-off (NP-15). Research Workspace questions feed anonymous trends only, and reach a named card solely for an academic who switched on 'contactable by pharma' (OQ-07, NP-03, FD-02). The 12 researchers of the August 2026 note are excluded from every list, card and profile (OQ-33). The negative-publication verification this build already had is unchanged and is what evidences the claim.

Still held. Nothing is held by a question. One operational bound stands and is not a gate: OncoSkepsis signals are shown only once a third hospital joins (NP-01, OQ-40), so a view with nothing releasable says so, naming the minimum, rather than showing an empty result.

Released by OQ-05, OQ-06, OQ-07, OQ-33, OQ-42, NP-03, NP-15, FD-02.

All of it, confirmed on 18/09/2026 and shaped by OQ-05 and OQ-18. A pharma user first meets an anonymous card: profession, country and topic, with no name, no employer and no question text. The profile proper opens only after the expert accepts a contact request, and then carries name, affiliation, specialty, the topic signal summary, the fit score, papers and trials. Optional fields appear when available: country, congress talks, guideline and society roles, grants, KOL type and last-updated dates. Every profile carries a completion score the customer can see, which sorts and scores nothing (OQ-18, NP-06). The expert may sign in with ORCID to fill the optional fields, see the topics flagged for them, and withdraw entirely (NP-06, FD-03). The 12 researchers of the August 2026 note appear nowhere (OQ-33).

Still held. Nothing. Two rules travel with the profile: a withdrawal deletes the expert's stored signals, recalculates the affected totals and re-applies the minimums (OQ-34, FD-03), and tumour-board membership appears only inside a revealed profile, never on a card, an export or an API answer that precedes an acceptance (NP-02).

Released by OQ-05, OQ-18, OQ-33, NP-02, NP-06, FD-03.

All of it, on the channels the answer names: a weekly email digest per user, and alerts written into the customer's CRM as tasks, for Veeva Vault CRM, Salesforce Life Sciences Cloud and IQVIA OCE (OQ-22, OQ-26). Subscriptions were already buildable; what was missing was where an alert goes and how often, and both are now stated rather than chosen here.

Still held. Nothing. Every alert carries the same suppression as the view it came from: the 8-person minimum, the 3-institution minimum with the dominance check, counts rounded to 5, and nobody named without an accepted contact request (OQ-14, OQ-40, OQ-05). An alert is a delivery channel, not an exemption.

Released by OQ-05, OQ-14, OQ-22, OQ-26, OQ-33, OQ-40, OQ-43.